Driehaus Capital Management announces with deep sadness the unexpected passing of its Founder, Richard H. Driehaus, of natural causes at the age of 78.
“Richard led a life of zest and intellectual curiosity. His path and personal story were larger than life, and the impact he made as an investor is perhaps only rivaled by the extensive legacy he left as a philanthropist,” said Driehaus President and CEO Steve Weber.Read more
Driehaus Capital Management is an independent boutique investment adviser managing long-only equity and multi-asset alternative strategies.
of institutional investment experience, founded in 1982 by renowned investor Richard H. Driehaus.
It is rare to have a conversation with a company management team or one of our clients, in recent months, without the topic of inflation arising. In this piece, we explore indicators that can give investors further insight into the level, trajectory, and behavioral impact of inflation.
We started writing Counting Cards in Biotech in early 2016. Since then, numerous new kinase inhibitors have been approved in genomically defined cancers. Despite a massive change in sentiment over the last five years, the opportunity in precision oncology does not look tapped-out to us.